199 related articles for article (PubMed ID: 32599724)
1. The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ Na
Alvarez-Collazo J; López-Requena A; Alvarez JL; Talavera K
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599724
[TBL] [Abstract][Full Text] [Related]
2. The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na
Alvarez-Collazo J; López-Requena A; Galán L; Talavera A; Alvarez JL; Talavera K
Br J Pharmacol; 2019 Apr; 176(8):1090-1105. PubMed ID: 30650182
[TBL] [Abstract][Full Text] [Related]
3. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
[TBL] [Abstract][Full Text] [Related]
4. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients.
Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH
Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085
[TBL] [Abstract][Full Text] [Related]
5. Eleclazine exhibits enhanced selectivity for long QT syndrome type 3-associated late Na
El-Bizri N; Xie C; Liu L; Limberis J; Krause M; Hirakawa R; Nguyen S; Tabuena DR; Belardinelli L; Kahlig KM
Heart Rhythm; 2018 Feb; 15(2):277-286. PubMed ID: 29017927
[TBL] [Abstract][Full Text] [Related]
6. Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide.
Nagatomo T; January CT; Makielski JC
Mol Pharmacol; 2000 Jan; 57(1):101-7. PubMed ID: 10617684
[TBL] [Abstract][Full Text] [Related]
7. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
8. Lidocaine attenuation testing: An in vivo investigation of putative LQT3-associated variants in the SCN5A-encoded sodium channel.
Anderson HN; Bos JM; Kapplinger JD; Meskill JM; Ye D; Ackerman MJ
Heart Rhythm; 2017 Aug; 14(8):1173-1179. PubMed ID: 28412158
[TBL] [Abstract][Full Text] [Related]
9. Temperature dependence of early and late currents in human cardiac wild-type and long Q-T DeltaKPQ Na+ channels.
Nagatomo T; Fan Z; Ye B; Tonkovich GS; January CT; Kyle JW; Makielski JC
Am J Physiol; 1998 Dec; 275(6):H2016-24. PubMed ID: 9843800
[TBL] [Abstract][Full Text] [Related]
10. Modeling incomplete penetrance in long QT syndrome type 3 through ion channel heterogeneity: an in silico population study.
Miller JA; Moise N; Weinberg SH
Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H179-H197. PubMed ID: 36487185
[TBL] [Abstract][Full Text] [Related]
11. Altered Na+ channels promote pause-induced spontaneous diastolic activity in long QT syndrome type 3 myocytes.
Fredj S; Lindegger N; Sampson KJ; Carmeliet P; Kass RS
Circ Res; 2006 Nov; 99(11):1225-32. PubMed ID: 17082480
[TBL] [Abstract][Full Text] [Related]
12. Multiple mechanisms underlie increased cardiac late sodium current.
Kroncke BM; Yang T; Roden DM
Heart Rhythm; 2019 Jul; 16(7):1091-1097. PubMed ID: 30677491
[TBL] [Abstract][Full Text] [Related]
13. 18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels.
Du YM; Xia CK; Zhao N; Dong Q; Lei M; Xia JH
Acta Pharmacol Sin; 2012 Jun; 33(6):752-60. PubMed ID: 22609834
[TBL] [Abstract][Full Text] [Related]
14. Selective block of late currents in the DeltaKPQ Na(+) channel mutant by pilsicainide and lidocaine with distinct mechanisms.
Ono K; Kaku T; Makita N; Kitabatake A; Arita M
Mol Pharmacol; 2000 Feb; 57(2):392-400. PubMed ID: 10648650
[TBL] [Abstract][Full Text] [Related]
15. Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3.
Iyer V; Roman-Campos D; Sampson KJ; Kang G; Fishman GI; Kass RS
Sci Rep; 2015 Aug; 5():13287. PubMed ID: 26289036
[TBL] [Abstract][Full Text] [Related]
16. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
[TBL] [Abstract][Full Text] [Related]
18. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
Potet F; Beckermann TM; Kunic JD; George AL
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Fredj S; Sampson KJ; Liu H; Kass RS
Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
[TBL] [Abstract][Full Text] [Related]
20. Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction.
Guzadhur L; Pearcey SM; Duehmke RM; Jeevaratnam K; Hohmann AF; Zhang Y; Grace AA; Lei M; Huang CL
Pflugers Arch; 2010 Aug; 460(3):593-601. PubMed ID: 20552221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
